Edy Hasrouni

571 total citations
17 papers, 374 citations indexed

About

Edy Hasrouni is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Edy Hasrouni has authored 17 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 9 papers in Genetics and 5 papers in Molecular Biology. Recurrent topics in Edy Hasrouni's work include Acute Myeloid Leukemia Research (14 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Edy Hasrouni is often cited by papers focused on Acute Myeloid Leukemia Research (14 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Edy Hasrouni collaborates with scholars based in United States, Brazil and Japan. Edy Hasrouni's co-authors include Valeria Visconte, Ramón V. Tiu, Mikkael A. Sekeres, Ali Tabarroki, Edward A. Copelan, Yogen Saunthararajah, Hideki Makishima, Anjali S. Advani, Fabı́ola Traina and Ania Jankowska and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Edy Hasrouni

15 papers receiving 371 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edy Hasrouni United States 5 264 225 108 44 43 17 374
Eva Lumbreras Spain 10 138 0.5× 146 0.6× 62 0.6× 22 0.5× 42 1.0× 23 306
Cassandra P. Loren United States 7 196 0.7× 111 0.5× 96 0.9× 31 0.7× 16 0.4× 8 342
Yajuan Cui China 10 119 0.5× 186 0.8× 95 0.9× 14 0.3× 49 1.1× 25 356
George Corpus Canada 7 129 0.5× 174 0.8× 62 0.6× 23 0.5× 40 0.9× 8 337
W.-K. Hofmann Germany 7 120 0.5× 159 0.7× 36 0.3× 22 0.5× 34 0.8× 9 268
Ronald Lekanne dit Deprez Netherlands 3 129 0.5× 117 0.5× 46 0.4× 32 0.7× 17 0.4× 3 283
Paula de Melo Campos Brazil 11 168 0.6× 147 0.7× 83 0.8× 7 0.2× 28 0.7× 43 353
Susana Bizarro Portugal 12 118 0.4× 165 0.7× 39 0.4× 29 0.7× 66 1.5× 29 335
Isabel Moreno–Miralles United States 9 92 0.3× 200 0.9× 22 0.2× 17 0.4× 35 0.8× 9 291
Nirmalee Abayasekara United States 5 107 0.4× 268 1.2× 54 0.5× 12 0.3× 27 0.6× 5 368

Countries citing papers authored by Edy Hasrouni

Since Specialization
Citations

This map shows the geographic impact of Edy Hasrouni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edy Hasrouni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edy Hasrouni more than expected).

Fields of papers citing papers by Edy Hasrouni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edy Hasrouni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edy Hasrouni. The network helps show where Edy Hasrouni may publish in the future.

Co-authorship network of co-authors of Edy Hasrouni

This figure shows the co-authorship network connecting the top 25 collaborators of Edy Hasrouni. A scholar is included among the top collaborators of Edy Hasrouni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edy Hasrouni. Edy Hasrouni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Hamilton, Betty K., Valeria Visconte, Xuefei Jia, et al.. (2016). Impact of allogeneic hematopoietic cell transplant in patients with myeloid neoplasms carrying spliceosomal mutations. American Journal of Hematology. 91(4). 406–409. 14 indexed citations
2.
Ai, Jing, Valeria Visconte, Ali Tabarroki, et al.. (2015). Non-t(6;9) and Non-Inv(3) Balanced Chromosomal Rearrangements Are Associated With Poor Survival Outcomes in Myelodysplastic Syndromes. Clinical Lymphoma Myeloma & Leukemia. 15(8). 489–495. 1 indexed citations
3.
Visconte, Valeria, Reda Z. Mahfouz, Ali Tabarroki, et al.. (2014). Distinct iron architecture in SF3B1-mutant myelodysplastic syndrome patients is linked to an SLC25A37 splice variant with a retained intron. Leukemia. 29(1). 188–195. 48 indexed citations
4.
Visconte, Valeria, Ali Tabarroki, Li Zhang, et al.. (2014). Splicing factor 3b subunit 1 (Sf3b1) haploinsufficient mice display features of low risk Myelodysplastic syndromes with ring sideroblasts. Journal of Hematology & Oncology. 7(1). 89–89. 17 indexed citations
5.
Traina, Fabı́ola, Valeria Visconte, Paul Elson, et al.. (2013). Impact of molecular mutations on treatment response to DNMT inhibitors in myelodysplasia and related neoplasms. Leukemia. 28(1). 78–87. 219 indexed citations
6.
Hamilton, Betty K., Ali Tabarroki, Paul Elson, et al.. (2013). Impact of allogeneic hematopoietic stem cell transplant (HSCT) on patients harboring the spliceosome mutation SRSF2.. Journal of Clinical Oncology. 31(15_suppl). 7008–7008. 4 indexed citations
7.
Hasrouni, Edy, Heesun J. Rogers, Ali Tabarroki, et al.. (2013). A case of mistaken identity: When lupus masquerades as primary myelofibrosis. SHILAP Revista de lepidopterología. 1. 2050313X13498709–2050313X13498709. 3 indexed citations
8.
Tabarroki, Ali, Valeria Visconte, Heesun J. Rogers, et al.. (2013). Spliceosome Gene Mutations Are Frequently Found In JAK2 Negative Myelofibrosis and Associated With Worse Clinical Outcomes. Blood. 122(21). 4063–4063. 1 indexed citations
9.
Visconte, Valeria, Reda Z. Mahfouz, Ali Tabarroki, et al.. (2013). BCL-2 Family Of Genes Is a Key Regulator In The Pathogenesis Of SF3B1 Mutant and Wild Type MDS With Ring Sideroblasts and Represents a Novel Drug Target In This Disease. Blood. 122(21). 263–263. 1 indexed citations
10.
Visconte, Valeria, Heesun J. Rogers, Ali Tabarroki, et al.. (2013). Splicing Factor 3b Subunit 1 (SF3B1) Heterozygous Mice Manifest a Hematologic Phenotype Similar To Low Risk Myelodysplastic Syndromes With Ring Sideroblasts. Blood. 122(21). 259–259. 2 indexed citations
11.
12.
Liu, Yang, Ali Tabarroki, Valeria Visconte, et al.. (2012). A Prognostic Scoring System for Unclassifiable MDS and MDS/MPN. Blood. 120(21). 1701–1701. 3 indexed citations
13.
14.
Afelik, Solomon, Edy Hasrouni, Michael A. Bukys, et al.. (2012). Notch-mediated patterning and cell fate allocation of pancreatic progenitor cells. Development. 139(10). 1744–1753. 54 indexed citations
15.
16.
17.
Afelik, Solomon, et al.. (2011). Notch mediated patterning and cell fate allocation of pancreatic progenitor cells. Developmental Biology. 356(1). 168–168. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eva Lumbreras Breakdown of academic impact, for papers by Cassandra P. Loren Breakdown of academic impact, for papers by Yajuan Cui Breakdown of academic impact, for papers by George Corpus Breakdown of academic impact, for papers by W.-K. Hofmann Breakdown of academic impact, for papers by Ronald Lekanne dit Deprez Breakdown of academic impact, for papers by Paula de Melo Campos Breakdown of academic impact, for papers by Susana Bizarro Breakdown of academic impact, for papers by Isabel Moreno–Miralles Breakdown of academic impact, for papers by Nirmalee Abayasekara
Rankless by CCL
2026